Are current SGLT2 Inhibitors efficacious treatment options for Type 1 diabetes?

Expert Opin Pharmacother. 2021 Mar 23:1-3. doi: 10.1080/14656566.2021.1900824. Online ahead of print.NO ABSTRACTPMID:33754937 | DOI:10.1080/14656566.2021.1900824

Source: Expert Opinion on Pharmacotherapy - March 23, 2021 Category: Drugs & Pharmacology Authors: Yoko Koike Yasuo Terauchi Source Type: research